134 related articles for article (PubMed ID: 1895307)
1. Nucleosides and nucleotides. 100. 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosyl-cytosine (CNDAC): design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside.
Matsuda A; Nakajima Y; Azuma A; Tanaka M; Sasaki T
J Med Chem; 1991 Sep; 34(9):2917-9. PubMed ID: 1895307
[No Abstract] [Full Text] [Related]
2. Nucleosides and nucleotides. 141. Chemical stability of a new antitumor nucleoside, 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine in alkaline medium: formation of 2'-C-cyano-2'-deoxy-1-beta-D-ribo-pentofuranosylcytosine and its antitumor activity.
Azuma A; Hanaoka K; Kurihara A; Kobayashi T; Miyauchi S; Kamo N; Tanaka M; Sasaki T; Matsuda A
J Med Chem; 1995 Aug; 38(17):3391-7. PubMed ID: 7650692
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl) cytosine) and its N4-palmitoyl derivative (CS-682).
Hanaoka K; Suzuki M; Kobayashi T; Tanzawa F; Tanaka K; Shibayama T; Miura S; Ikeda T; Iwabuchi H; Nakagawa A; Mitsuhashi Y; Hisaoka M; Kaneko M; Tomida A; Wataya Y; Nomura T; Sasaki T; Matsuda A; Tsuruo T; Kurakata S
Int J Cancer; 1999 Jul; 82(2):226-36. PubMed ID: 10389757
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of a novel nucleoside, 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine (CNDAC) against murine and human tumors.
Tanaka M; Matsuda A; Terao T; Sasaki T
Cancer Lett; 1992 May; 64(1):67-74. PubMed ID: 1596880
[TBL] [Abstract][Full Text] [Related]
5. Nucleosides and nucleotides. 122. 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine and its derivatives. A new class of nucleoside with a broad antitumor spectrum.
Azuma A; Nakajima Y; Nishizono N; Minakawa N; Suzuki M; Hanaoka K; Kobayashi T; Tanaka M; Sasaki T; Matsuda A
J Med Chem; 1993 Dec; 36(26):4183-9. PubMed ID: 8277499
[TBL] [Abstract][Full Text] [Related]
6. [Design of a new antitumor nucleoside CNDAC, against solid tumors].
Matsuda A
Gan To Kagaku Ryoho; 1996 Jan; 23(2):202-10. PubMed ID: 8611048
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of a novel orally effective nucleoside, 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine.
Miura S; Yoshimura Y; Endo M; Machida H; Matsuda A; Tanaka M; Sasaki T
Cancer Lett; 1998 Jul; 129(1):103-10. PubMed ID: 9714341
[TBL] [Abstract][Full Text] [Related]
8. Mechanism-Based Drug Combinations with the DNA Strand-Breaking Nucleoside Analog CNDAC.
Liu X; Jiang Y; Nowak B; Hargis S; Plunkett W
Mol Cancer Ther; 2016 Oct; 15(10):2302-2313. PubMed ID: 27474148
[TBL] [Abstract][Full Text] [Related]
9. Cellular pharmacokinetics and pharmacodynamics of the deoxycytidine analog 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine (CNDAC).
Azuma A; Huang P; Matsuda A; Plunkett W
Biochem Pharmacol; 2001 Jun; 61(12):1497-507. PubMed ID: 11377379
[TBL] [Abstract][Full Text] [Related]
10. 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine: a novel anticancer nucleoside analog that causes both DNA strand breaks and G(2) arrest.
Azuma A; Huang P; Matsuda A; Plunkett W
Mol Pharmacol; 2001 Apr; 59(4):725-31. PubMed ID: 11259616
[TBL] [Abstract][Full Text] [Related]
11. Repair of 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine-induced DNA single-strand breaks by transcription-coupled nucleotide excision repair.
Wang Y; Liu X; Matsuda A; Plunkett W
Cancer Res; 2008 May; 68(10):3881-9. PubMed ID: 18483273
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 2,2'-anhydro-1-(3'-Ok-acetyl-beta-D-arabinofuranosyl)-5-iodocytosine hydrochloride and related compounds as antineoplastic and antiviral agents.
Itoh YH; Chu MY; Chang PK; Allaudeen HS; Sartorelli AC
Chem Biol Interact; 1981 Jan; 33(2-3):215-27. PubMed ID: 6257405
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of a new potent antitumor nucleoside, 2'-C-cyano-2'-deoxy-1-beta-D- arabinofuranosylcytosine.
Matsuda A; Nakajima Y; Azuma A; Sasaki T; Ueda T
Nucleic Acids Symp Ser; 1990; (22):51-2. PubMed ID: 2101914
[No Abstract] [Full Text] [Related]
14. Molecular basis for G2 arrest induced by 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine and consequences of checkpoint abrogation.
Liu X; Guo Y; Li Y; Jiang Y; Chubb S; Azuma A; Huang P; Matsuda A; Hittelman W; Plunkett W
Cancer Res; 2005 Aug; 65(15):6874-81. PubMed ID: 16061671
[TBL] [Abstract][Full Text] [Related]
15. Deletion mutants of human deoxycytidine kinase mRNA in cells resistant to antitumor cytosine nucleosides.
Obata T; Endo Y; Tanaka M; Uchida H; Matsuda A; Sasaki T
Jpn J Cancer Res; 2001 Jul; 92(7):793-8. PubMed ID: 11473731
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine with gemcitabine in its antitumor activity.
Miura S; Yoshimura Y; Endo M; Satoh H; Machida H; Sasaki T
Cancer Lett; 1999 Oct; 144(2):177-82. PubMed ID: 10529018
[TBL] [Abstract][Full Text] [Related]
17. Anticancer activity of beta-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration.
Grove KL; Guo X; Liu SH; Gao Z; Chu CK; Cheng YC
Cancer Res; 1995 Jul; 55(14):3008-11. PubMed ID: 7606719
[TBL] [Abstract][Full Text] [Related]
18. Sapacitabine, the prodrug of CNDAC, is a nucleoside analog with a unique action mechanism of inducing DNA strand breaks.
Liu XJ; Nowak B; Wang YQ; Plunkett W
Chin J Cancer; 2012 Aug; 31(8):373-80. PubMed ID: 22739266
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic liponucleotide analogs. II. Antitumor activity of CDP-diacylglycerol analogs containing the cytosine arabinoside moiety.
Turcotte JG; Srivastava SP; Steim JM; Calabresi P; Tibbetts LM; Chu MY
Biochim Biophys Acta; 1980 Sep; 619(3):619-31. PubMed ID: 7459369
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anticancer activity of various 3'-deoxy pyrimidine nucleoside analogues and crystal structure of 1-(3-deoxy-beta-D-threo-pentofuranosyl)cytosine.
Lin TS; Yang JH; Liu MC; Shen ZY; Cheng YC; Prusoff WH; Birnbaum GI; Giziewicz J; Ghazzouli I; Brankovan V
J Med Chem; 1991 Feb; 34(2):693-701. PubMed ID: 1995894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
